Research.Patient.info
mCRPC (Metastatic Castration-resistant Prostate Cancer) research hub
2 indexed studies · 2 currently recruiting
- recruitingPHASE1, PHASE2
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
This study looks at a new drug combination, Gedatolisib and Darolutamide, for men with prostate cancer that has spread and is no longer responding to standard hormone therapy. It helps work out the best dose and how well it works.
United States · France · Spain - recruitingNA
Four-Timepoint Multi-tracer PET Imaging to Characterize Metastatic prOstate Cancer Heterogeneity
This study uses special scans, called PET scans, to look closely at how prostate cancer cells behave in different places in the body. It aims to understand why some cancer spots grow and others shrink during treatment, helping to find better ways to fight advanced prostate cancer.
Canada